Communicating and Promoting Comparative-Effectiveness Research Findings — NEJM

Retweeted NEJM (@NEJM): Tufts’ Neumann argues to allow pharma more flexible B2B communication of CER findings. http://t.co/SPmpm9czCN

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/SPmpm9czCN